Modular Medical Inc (MODD)
Health Services • Health Care
June 29, 2026 Modular Medical Inc. Reports Challenging Financial Year 2026: A Deep Dive into Results and Future Prospects Modular Medical Inc. reported a net loss of $28.2 million for FY 2026, raising concerns about its financial stability despite advancements in product development. The company faces challenges in raising capital while striving for successful product commercialization in the diabetes management market.
February 17, 2026 Modular Medical Inc. Reports Q3 2026 Results: Strategic Shifts and Financial Outlook Modular Medical Inc. reported a significant net loss of $7.36 million in Q3 2026, driven by increased R&D costs. As the company shifts focus to launch its new Pivot insulin pump, it faces challenges in compliance and liquidity, but remains optimistic about future prospects.
November 14, 2025 Modular Medical Inc. Reports Q2 2026 Financial Results: A Mixed Bag of Developments Modular Medical Inc. faced a net loss of $7.79 million in Q2 2026 while advancing its insulin pump development. Despite financial challenges, the company is poised for growth with promising product innovations and strategic financing efforts.
August 14, 2025 Modular Medical Inc. Reports 2026 Q1 Financial Results: A Closer Look at the Numbers Modular Medical Inc. reported a net loss of $6.7 million in Q1 2026 amid challenges in funding and operational sustainability. The company is focused on advancing its MODD1 insulin pump and seeks regulatory approval for its Pivot product while facing significant accumulated losses and a critical financial outlook.
June 20, 2025 Modular Medical Inc. Reports 2025 Annual Results: Navigating a Challenging Financial Landscape Modular Medical Inc. reported a net loss of $18.82 million for 2025, driven by significant R&D investments in its MODD1 insulin pump. Despite ongoing challenges, the company is strategically positioned for future growth as it prepares for product launch and seeks additional funding.
March 18, 2025 SWOT Analysis of Modular Medical Inc in 2025 This SWOT analysis of Modular Medical Inc. in 2025 highlights its innovative MODD1 insulin pump and significant market opportunities in diabetes management. However, the company faces financial challenges and competition that could impact its growth trajectory.
February 13, 2025 Modular Medical Inc. Reports Q3 2025 Financial Results: A Step Forward Amid Ongoing Losses Modular Medical Inc. announced its Q3 2025 financial results, showing a reduced net loss of $4.80 million as it prepares for the launch of the MODD1 insulin pump. Despite improving asset positions, liquidity challenges persist, raising concerns about long-term sustainability.
November 14, 2024 Modular Medical Inc. Reports Q2 2025 Financial Results: A Step Forward in Diabetes Management Modular Medical Inc. reported a net loss of $4.95 million in Q2 2025, reflecting rising operational costs. The company remains focused on advancing its MODD1 insulin pump and exploring partnerships to enhance diabetes management.
August 13, 2024 Modular Medical Inc. Reports Q1 2025 Results: A Closer Look at Financial Health and Future Prospects Modular Medical Inc. reported a net loss of $4.13 million in Q1 2025, driven by increased R&D expenses. Despite financial challenges, the company remains focused on developing its MODD1 insulin pump and improving diabetes management.
June 21, 2024 Modular Medical Inc. Reports 2024 Annual Financial Results: Focus on Growth Amid Continued Losses Modular Medical Inc. reported a net loss of $17.47 million for 2024, despite significant investments in R&D for its MODD1 insulin pump. With cash reserves boosting its position, the company aims for commercialization in late fiscal 2025, focusing on innovation in diabetes management.